antileishmaniasis therapy (Massachusetts University)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameantileishmaniasis therapy (Massachusetts University)
Drug Alias Namepteridine reductase inhibitors (Massachusetts University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFolic acid transporters modulators
TargetsFolic acid transporters
Therapy Area/IndicationsLeishmaniasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Massachusetts
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Massachusetts
Active IndicationsN/A
Inactive IndicationsLeishmaniasis

Other Information

ATC CodeN/A
Related LinksN/A